Type 2 Diabetes and Cardiovascular Diseases: Prevention and Treatment Strategies

• Autor(a) principal: Oliveira Cunha Fontes , Marianna
• Data de Publicação: 2023
• Outros Autores: Tomé de Sousa , André, Célio de Oliveira Junior, Antônio, Achtschin Fernandes, Brenda, Bretas dos Santos Leonha, Luana
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Brazilian Journal of Implantology and Health Sciences
• Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/885
• topic: Catarata. Diabetes Mellitus. Fatores de Risco; Type 2 Diabetes; Cardiovascular Diseases; Pharmacological Therapies.

The effective approach to the interaction between type 2 diabetes and cardiovascular diseases emerges as a complex challenge in clinical practice, requiring an integrative approach that considers various facets of prevention and treatment. Current intervention strategies for patients facing this conjunction of conditions emphasize the importance of a holistic view, incorporating both pharmacological and non-pharmacological approaches to provide comprehensive and personalized care. A critical literature review explores pharmacological interventions such as hypoglycemics, antihypertensives, and statins, while also examining non-pharmacological therapies such as lifestyle changes, dietary modifications, and exercise programs. The detailed analysis of these therapeutic modalities underscores the demand for a personalized approach in managing the interaction between type 2 diabetes and cardiovascular diseases, recognizing the diversity in individual responses to different interventions. Additionally, the growing role of multidisciplinary interventions is highlighted, fostering collaboration among various healthcare professionals, including endocrinologists, cardiologists, nutritionists, and health educators. This synergy aims to offer patients a variety of therapeutic options, taking into account the unique complexities associated with this clinically complex condition. Finally, this research emphasizes future implications and promising areas of study in managing the interaction between type 2 diabetes and cardiovascular diseases. This includes the development of innovative therapeutic approaches, advances in regenerative medicine, and a deeper understanding of the pathophysiological foundations of these interrelated conditions. By providing a comprehensive view of current and future strategies, this article seeks to genuinely contribute to improving the quality of life for patients facing challenges arising from the complex interaction between type 2 diabetes and cardiovascular diseases.